Propel Bio Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Propel Bio Management, LLC
- $172 Billion
- Q1 2024
A detailed history of Propel Bio Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 70,000 shares of MIRM stock, worth $2.81 Million. This represents 1.02% of its overall portfolio holdings.
Number of Shares
70,000
Previous 70,000
-0.0%
Holding current value
$2.81 Million
Previous $2.07 Billion
14.91%
% of portfolio
1.02%
Previous 1.71%
Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
183Shares Held
54.4MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$261 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$176 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$133 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$113 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$111 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.48B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...